Overview
This is a pilot open study to test the hypothesis that home-based transcranial static magnetic field stimulation (tSMS) of the supplementary motor area is safe and feasible to modulate corticostriatal activity in patients with Parkinson's disease.
Eligibility
Inclusion Criteria:
- idiopathic Parkinson's disease (Brain Bank criteria)
- optimal clinical response to dopaminergic medication (>30% MDS-UPDRS-III improvement)
Exclusion Criteria:
- MRI-incompatible metal objects in the body (e.g. cardiac pacemakers)
- presence of levodopa-induced dyskinesias
- other main neuropsychiatric co-morbidity